Recent Finacing
Recent Raise
NuSirt Biopharma develops a patented leucine-based platform pairing leucine with existing drugs (metformin, PDE5 inhibitors) to activate sirtuin pathways for Type 2 diabetes and NAFLD/NASH; Phase 2A trials underway.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors